We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+7.87%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
–
AUM
$9.04B
AUM Growth
+$2.19B
Cap. Flow
+$1.88B
Cap. Flow %
20.78%
Top 10 Hldgs %
34.88%
Holding
3,092
New
1,032
Increased
581
Reduced
587
Closed
820

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$435M
2
AMZN icon
Amazon
AMZN
+$334M
3
MRNA icon
Moderna
MRNA
+$53.9M
4
LIN icon
Linde
LIN
+$44.2M
5
DTE icon
DTE Energy
DTE
+$43.5M

Top Sells

Rank Stock Value
1
IWD icon
iShares Russell 1000 Value ETF
IWD
+$63.6M
2
CMCSA icon
Comcast
CMCSA
+$39.7M
3
EVRG icon
Evergy
EVRG
+$38.5M
4
PEG icon
Public Service Enterprise Group
PEG
+$38.4M
5
TECH icon
Bio-Techne
TECH
+$30.9M

Sector Composition

Rank Sector Weight
1 Technology 15.37%
2 Consumer Discretionary 10.36%
3 Financials 7.14%
4 Industrials 6.8%
5 Healthcare 6.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HYMC icon
2551
Hycroft Mining Holding Corp
HYMC
$2.52B
– –
-10,464
Closed -$366K
HZO icon
2552
MarineMax
HZO
$1.15B
– –
-10,328
Closed -$510K
IBM icon
2553
IBM
IBM
$222B
– –
-6,781
Closed -$864K
IBP icon
2554
Installed Building Products
IBP
$6.56B
– –
-11,715
Closed -$1.3M
IBRX icon
2555
ImmunityBio
IBRX
$8.26B
– –
-35,312
Closed -$838K
ICLN icon
2556
iShares Global Clean Energy ETF
ICLN
$2.2B
– –
-134,713
Closed -$3.27M
IDA icon
2557
Idacorp
IDA
$7.94B
– –
-58,470
Closed -$5.84M
IHRT icon
2558
iHeartMedia
IHRT
$432M
– –
-52,173
Closed -$947K
IIIN icon
2559
Insteel Industries
IIIN
$599M
– –
-11,127
Closed -$343K
ILPT
2560
Industrial Logistics Properties Trust
ILPT
$554M
– –
-14,903
Closed -$345K
NBP
2561
NovaBridge Biosciences American Depositary Shares
NBP
$231M
– –
-254,443
Closed -$12.3M
IMKTA icon
2562
Ingles Markets
IMKTA
$1.61B
– –
-4,044
Closed -$249K
IMUX icon
2563
Immunic
IMUX
$225M
– –
-1,529
Closed -$244K
IMXI icon
2564
International Money Express
IMXI
$427M
– –
-22,393
Closed -$336K
INFY icon
2565
Infosys
INFY
$48.4B
– –
-52,093
Closed -$975K
INMB icon
2566
INmune Bio
INMB
$64.4M
– –
-17,073
Closed -$203K
INSM icon
2567
Insmed
INSM
$27.5B
– –
-67,008
Closed -$2.28M
INTU icon
2568
Intuit
INTU
$100B
– –
-22,675
Closed -$8.69M
IPI icon
2569
Intrepid Potash
IPI
$525M
– –
-13,164
Closed -$429K
ITRI icon
2570
Itron
ITRI
$4.38B
– –
-14,764
Closed -$1.31M
IVE icon
2571
iShares S&P 500 Value ETF
IVE
$50.2B
– –
-25,939
Closed -$3.66M
JAGX icon
2572
Jaguar Health
JAGX
$4.26M
– –
0
– -$200K
JAZZ icon
2573
Jazz Pharmaceuticals
JAZZ
$16.5B
– –
-2,301
Closed -$378K
JBSS icon
2574
John B. Sanfilippo & Son
JBSS
$862M
– –
-3,336
Closed -$301K
JEF icon
2575
Jefferies Financial Group
JEF
$12.1B
– –
-83,163
Closed -$2.39M
101 102
103
104 105

Similar funds

FGP
Freestone Grove Partners San Francisco, California $15.6B AUM 27.39% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
AA
Acorns Advisers Irvine, California $15.3B AUM 18.32% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $15.8B AUM 1.29% 1-Year Est. Return
NMIFOAC
National Mutual Insurance Federation of Agricultural Cooperatives Tokyo, Japan, Japan $15.3B AUM 24.71% 1-Year Est. Return

Michael Gelband's Q2 2021 Portfolio in Review

As of Q2 2021, Michael Gelband held 3,092 positions worth $9.04B, up 32% from $6.86B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Michael Gelband deployed $1.88B of net new capital in Q2 2021, opening 1,032 new positions and adding to 581 existing holdings. Its largest new stake was Linde: 151,692 shares worth $43.9M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 1000 Value ETF, an estimated $63.6M trimmed.

  • Michael Gelband's largest Q2 2021 buy was Linde: 151,692 shares worth $43.9M.
  • Michael Gelband added most to Microsoft in Q2 2021, an estimated $435M increase.
  • Michael Gelband's biggest Q2 2021 reduction was iShares Russell 1000 Value ETF, cutting an estimated $63.6M.
  • Michael Gelband fully exited Charles River Laboratories in Q2 2021, selling an estimated $27.9M.
  • Michael Gelband's ten largest holdings make up 35% of its $9.04B portfolio in Q2 2021.
  • Michael Gelband opened 1,032 new positions and closed 820 in Q2 2021.
  • Michael Gelband's portfolio value rose 32% quarter-over-quarter to $9.04B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.